1Bystanders or not? Microglia and lymphocytes in aging and strokeJustin N.Nguyen, Anjali Chauhan1397-14032Alzheimer's disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegenerationEugenia Olivera, Albany Sáez, Lila Carniglia, Carla Caruso, Mercedes Lasaga, Daniela Durand1404-14103Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseasesAna M.Sandoval-Castellanos, Anushka Bhargava, Min Zhao, Jun Xu, Ke Ning1411-14164Can glial cells save neurons in epilepsy?Weida Shen, Jelena Bogdanovi? Pristov, Paola Nobili, Ljiljana Nikoli?1417-14225Lights for epilepsy: can photobiomodulation reduce seizures and offer neuroprotection?Napoleon Torres-Martinez, Stephan Chabardes, John Mitrofanis1423-14266The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosisIlaria Martinelli, Elisabetta Zucchi, Cecilia Simonini, Giulia Gianferrari, Giovanna Zamboni, Marcello Pinti, Jessica Mandrioli1427-14337CMT1A current gene therapy approaches and promising biomarkersMarina Stavrou, Kleopas A.Kleopa1434-14408Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surfaceDan-Dan Liu, Chao-Yang Zhang, Jing-Ting Zhang, Li-Min Gu, Guo-Tong Xu, Jing-Fa Zhang1441-14499Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's diseaseTamara Andrea Alarcón, Sarah Martins Presti-Silva, Ana Paula Toniato Sim?es, Fabiola Mara Ribeiro, Rita Gomes Wanderley Pires1450-145610Regulation of enolase activation to promote neural protection and regeneration in spinal cord injuryHannah M.McCoy, Rachel Polcyn, Naren L.Banik, Azizul Haque1457-146211Converging links between adult-onset neurodegenerative Alzheimer's disease and early life neurodegenerative neuronal ceroid lipofuscinosis?Marcel Klein, Guido Hermey1463-147112Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategiesAnamaria Jurcau, Carolina Maria Jurcau1472-147713Stem cell therapy in retinal diseasesAudrey Voisin, Amaury Pénaguin, Afsaneh Gaillard, Nicolas Leveziel1478-148514Overcoming mitochondrial dysfunction in neurodegenerative diseasesJo?o Pessoa, Ana I.Duarte1486-148815Functional hyperconnectivity related to brain disease: maladaptive process or element of resilience?Markus Aswendt, Mathias Hoehn1489-149016Aquaporin 5 in Alzheimer's disease: a link between oral and brain pathology?Cristina Municio, Eva Carro1491-149217Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?Jorge Pascual-Guerra, José A.Rodríguez-Navarro, Carlos L.Paíno1493-149418Pemafibrate, a potent selective peroxisome proliferator-activated receptor α modulator, a promising novel treatment for ischemic retinopathy?Deokho Lee, Yohei Tomita, Kazuno Negishi, Toshihide Kurihara1495-149619From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic painReece A.Sophocleous, Ronald Sluyter1497-149820Mutations in Hevin/Sparcl1 and risk of autism spectrum disorderTakumi Taketomi, Fuminori Tsuruta1499-1500 